Wakefield Asset Management’s Abbott ABT Stock Holding History

Wakefield Asset Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,459	Closed	-$491K	–	145
2023 Q4	$491K	Buy	+4,459	New	+$446K	0.18%	129

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wakefield Asset Management's ABT Position: Q1 2024 in Review

Wakefield Asset Management sold out of Abbott (ABT) in Q1 2024, closing a stake of 4,459 shares — an estimated $491K sold.

Wakefield Asset Management first reported a position in ABT in Q4 2023 and held it in 1 quarter. The position peaked at $491K in Q4 2023. 2,905 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

Wakefield Asset Management reported no remaining Abbott position as of Q1 2024 after selling out during the quarter.
Wakefield Asset Management sold 4,459 Abbott shares in Q1 2024, an estimated $491K.
Wakefield Asset Management first reported a position in Abbott in Q4 2023 and held it in 1 quarter.
Wakefield Asset Management's Abbott position peaked at $491K in Q4 2023.
2,905 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on Wakefield Asset Management's 13F filing for Q1 2024, filed 1 May 2024.